Testing the Argos System to measure heart blood flow
Treatments studied
Part of Heart & circulation clinical trials.
This trial is testing a new system called Argos to see if it can measure how much blood your heart pumps more easily than current methods. It is for patients already in the ICU who need a quick change in fluids or blood pressure medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently staying in the intensive care unit (ICU).
- You have a special heart monitor already in place that uses temperature changes to measure blood flow (called transpulmonary thermodilution).
- Your doctor plans to give you extra fluids through an IV or adjust a medication called norepinephrine (used to raise blood pressure) to help your heart.
- You are not pregnant.
- Your family (or you) agree to join the study, and a study doctor is available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a standard IV fluid bolus affects blood flow and heart function in ICU patients. It aims to better understand the body's response to this common treatment.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial studies different ways to measure how much extra fluid your body can handle when you are in shock. The goal is to see which method works best and helps doctors make better decisions about fluid treatment.
This trial tests a medicine called angiotensin II to see how well it helps people whose blood pressure stays dangerously low after standard treatments for vasoplegic shock, a condition where blood vessels relax too much. If it works, it might help raise blood pressure and improve blood flow to vital organs.
This study compares individualized blood pressure goals versus the usual (standard) targets for adults in the ICU with shock. The aim is to see whether tailored blood pressure treatment can improve outcomes by better matching each person’s needs.
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.